ow beauti routin
strong result
rate el ow believ market undervalu
est lt growth potenti favor exposur
high growth channel within high growth prestig beauti
categori well potenti near-term ep upsid
robust top-line momentum continu vacil intra-quart
concern china/travel retail macro slowdown weak us holiday result
impact french protest el fundament surpris upsid
result headlin impress organ sale growth vs
market expect profit beat vs consensu along
strong organ sale guidanc bp organ sale
guidanc rais drove jump stock vs rise
fundament strength continu driven asia pacif organ sale
y-o-i led acceler prestig categori growth china
underpin favor demograph grow middl class despit
macro slowdown forward growth potenti support announc tax
cut emea organ sale growth increas driven strong double-digit
growth travel retail middl east importantli corpor average
organ sale growth ex acquisit acceler straight quarter
highest level modern histori momentum continu
albeit lower rate growth given el experienc impact
weaker china macro date prestig categori growth actual
acceler highlight categori secular growth driver
place somewhat protect macro volatil ii el cite
expect much impact daigou travel retail enforc given strict
purchas limit channel anoth increment posit iii el brand
invest remain healthi spend bp y-o-i
sale continu support forward growth iv el
expect improv sequenti trend america organ sale
declin weak holiday season although januari weaker
weather govern shutdown impact net result provid us
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
increas convict view el pois deliv upsid vs fy
guidanc detail short-term importantli support view
hsd lt el top-line growth potenti reiter ow expect el
continu deliv best-in-class organ top-line growth driven strong
prestig beauti categori growth el market share gain fuel recent
reinvest outsiz el growth high growth channel also see el
march analyst meet potenti catalyst
strong visibl ep beat rais stori continu
balanc year assum el deliv high end organ sale
guidanc achiev high end el guidanc rang one
would need assum org sale growth slow bp vs
bp averag basi vs
thu even high end el target appear
ampl flexibl absorb potenti slowdown china travel retail
ep line el guidanc assum continu heavi innovation-l
reinvest busi well ad cost china tariffs/brexit
rais ep estim price follow stronger expect
result rais ep estim
high end el guidanc driven larg topline/margin upsid well
lower tax rate ep move rais pt
base ebitda estim note roll
forward pt estim
number el adj ep well ahead
consensu estim mse el impli guidanc rang
robust top-line growth better expect gross margin greater sg
growth market expect el guidanc
consensu adjust accounting/fx led upsid asia pacif
emea off-set weak america report
top-line beat amplifi bp gm beat tighter expens control
sg sale bp consensu lead strong
profit beat vs consensu profit line ep flatter cent
benefit tax vs forecast el also repurchas share
dilut s/o
ep guidanc rais lower tax rate account impact el rais
ep guidanc midpoint vs
prior high end given el typic conserv guidanc
prior consensu ep guidanc includ cent fx
headwind vs cent prior cent account impact new revenu
recognit standard vs cent prior lower tax rate vs
prior provid increment cent tailwind fy guidanc rais
local currenc sale growth vs prior seem conserv
impli org sale assum el meet high end top-line
guidanc report sale expect increas vs prior base
impact fx vs prior account impact new revenu
recognit standard vs prior regard el guid local
currenc sale growth report growth includ
impact fx benefit new account standard adj ep
expect includ cent ep impact fx cent
benefit new account standard
consensu midpoint el usual guid next quarter ep
conserv consensu guidanc good sign
exhibit el organ sale growth acceler two-yr averag basi
high growth potenti price valuat
high growth potenti price valuat
line base case assumpt
top-line margin upsid revenu upsid travel retail bp
price drive top-line upsid lt forecast el also deliv
cost-cut upsid valuat expand ebitda buoy
peer-lead topline/ep growth e-commerc china travel retail drive
strong organ revenu growth five-year compound-annual-growth-rate cost-cut top-line
leverag drive annual underli margin expans bps/year
top-line slowdown top-line miss china slowdown
tariffs/boycott travel retail drop bp global impact
weaker macro valuat contract ebitda
organ sale growth re-acceler
ldd rang well cpg
peer lsd rang growth gap
widen recent quarter view el
top-line out-performance sustain long
term albeit lesser magnitud strong
high growth area travel retail
e-commerc el
disproportion exposur increas
self-help driver unlock
sharehold valu believ two
el drive sharehold valu
cost-cut margin expans
low given much higher topline/ep
risk achiev price
risk includ china result slow
price unfavor fx
valu
exhibit bear bull driver travel retail cost-cut
sale
sale
sale bp chang
sell gener admin
sale
sale bp chang
provis incom tax
net incom minor
net incom non-controlling interest
cash equival
depreci amort
increas decreas oper work capit
provid oper
acquisit businesses/intang asset
use invest
net increas decreas short-term debt
net increas decreas long-term debt
net proce stock option transact
excess tax benefit stock option
purchas treasuri share
debt issuanc cost settlement deriv etc
use financ
provid discontinu oper
effect exchang rate
net increas decreas
equiv beg
equiv end
